Your browser doesn't support javascript.
loading
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.
Pollock, Katrina M; Cheeseman, Hannah M; Szubert, Alexander J; Libri, Vincenzo; Boffito, Marta; Owen, David; Bern, Henry; O'Hara, Jessica; McFarlane, Leon R; Lemm, Nana-Marie; McKay, Paul F; Rampling, Tommy; Yim, Yee Ting N; Milinkovic, Ana; Kingsley, Cherry; Cole, Tom; Fagerbrink, Susanne; Aban, Marites; Tanaka, Maniola; Mehdipour, Savviz; Robbins, Alexander; Budd, William; Faust, Saul N; Hassanin, Hana; Cosgrove, Catherine A; Winston, Alan; Fidler, Sarah; Dunn, David T; McCormack, Sheena; Shattock, Robin J.
Afiliação
  • Pollock KM; Department of Infectious Disease, Imperial College London.
  • Cheeseman HM; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Szubert AJ; Department of Infectious Disease, Imperial College London.
  • Libri V; MRC Clinical Trials Unit at UCL, London, UK.
  • Boffito M; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
  • Owen D; Department of Infectious Disease, Imperial College London.
  • Bern H; Chelsea & Westminster Hospital, London.
  • O'Hara J; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • McFarlane LR; MRC Clinical Trials Unit at UCL, London, UK.
  • Lemm NM; Department of Infectious Disease, Imperial College London.
  • McKay PF; Department of Infectious Disease, Imperial College London.
  • Rampling T; Department of Infectious Disease, Imperial College London.
  • Yim YTN; Department of Infectious Disease, Imperial College London.
  • Milinkovic A; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
  • Kingsley C; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
  • Cole T; Chelsea & Westminster Hospital, London.
  • Fagerbrink S; Department of Infectious Disease, Imperial College London.
  • Aban M; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Tanaka M; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Mehdipour S; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Robbins A; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Budd W; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Faust SN; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Hassanin H; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Cosgrove CA; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Winston A; Surrey Clinical Research Facility, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
  • Fidler S; Centre for Infection, St George's, University of London, London, United Kingdom.
  • Dunn DT; Department of Infectious Disease, Imperial College London.
  • McCormack S; Department of Infectious Disease, Imperial College London.
  • Shattock RJ; MRC Clinical Trials Unit at UCL, London, UK.
EClinicalMedicine ; 44: 101262, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35043093
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article